Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07223749
- Status
- Recruiting
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Under-diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is prevalent, with an estimated 75% of adults suffering from COPD in the US, without clinical recognition. Often, the first diagnosis of COPD comes with a flare or exacerbation. In one study, 34% of patients were first diagnosed during hospitalization for an exacerbation, an event associated with a 1-year mortality rate of 26%. When COPD is finally diagnosed, it is often in the late stages, with an average lung function of 50% of normal. Conversely, COPD can be over-diagnosed, defined as symptoms in an individual without airflow obstruction. Over-diagnosed people have significantly higher rates of hospitalization, ER visits, and ambulatory care visits because individuals are treated for a disorder they don't have and are not being treated for the disorder they do have. Lack of diagnostic clarity places patients at risk of medication complications without potential benefit. Conversely, failure to diagnose preempts the benefits of therapy. To date, no reliable solution has been found to address this problem.
Key Dates
- Start date
- Aug 22, 2025
- Status verified
- Oct 2025
- Primary completion
- Aug 30, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
obtainment of the accuracy of a model for predicting the presence of obstruction on spirometry [ Time Frame: minute 10 ]
Central Contacts
- Brian J Wells, MD336-257-7128
- Lynnette Harris, BSN336-716-8791
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | Brian J Wells, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Winston-Salem, NC
Related Studies
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePHASE3 · Recruiting · AstraZeneca · Athens, Alabama
- Photon-counting CT in Chest ImagingRecruiting · Duke University · Durham, North Carolina
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With HypoxemiaPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina
- Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPDRecruiting · University of California, San Francisco · San Francisco, California